Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: A population-based study

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 183-188

  Panero, F ^a   Gruden, G ^a   Perotto, M ^a   Fornengo, P ^a   Barutta, F ^a   Greco, E ^a   Runzo, C ^a   Ghezzo, G ^b   Cavallo Perin, P ^a   Bruno, Graziella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

Cardiovascular diseases; Diabetes; Mortality; Survey; Uric acid

Indexed keywords

DIURETIC AGENT; HEMOGLOBIN A1C; INSULIN; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERURICEMIA; ITALY; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; URIC ACID;

EID: 84857032951     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.042     Document Type: Article

References (28)

1. Blankenberg S., Zeller T., Saarela O., et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010, 121:2381-2383.
2. Melander O., Newton-Cheh C., Almgren P., et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009, 302:49-57.
3. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
4. Iseki K., Ikemiya Y., Inoue T., et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004, 44:642-650.
5. Johnson R.J., Kang D.H., Feig D., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension 2003, 41:1183-1190.
6. Niskanen L.K., Laaksonen D.E., Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
7. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
8. Strasak A.M., Kelleher C.C., Brant L.J., et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008, 125:232-239.
9. Strasak A., Ruttmann E., Brant L., et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008, 54:273-284.
10. Ioachimanescu A.G., Brennan D.M., Hoar B.M., Hazen S.L., Hoogwerf B.J. Serum uric acid is an indipendent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (Pre CIS) database cohort study. Arthritis Rheum 2008, 58:623-630.
11. Jee S.A., Soon Y.L., Kim M.T. Serum uric acid and risk of death from cancer, cardiovascular disease or all cause in men. Eur J Cardiovasc Prev Rehabil 2004, 11:185-191.
12. Mazza A., Zamboni S., Rizzato E., et al. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin dependent diabetic elderly people. The Cardiovascular Study in the Elderly (CASTEL). Acta Diabetol 2007, 44:99-105.
13. Zoppini G., Targher G., Negri C., et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009, 32:1716-1720.
14. Bruno G., Merletti F., Bargero G., et al. Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato Surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 2008, 18:39-45.
15. Bruno G., Merletti F., Biggeri A., et al. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2005, 48:427-434.
16. Bruno G., Merletti F., Bargero G., et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2007, 50:941-948.
17. Bonora E., Kiechl S., Willeit J., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007, 30:318-324.
18. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death. Ann Intern Med 1999, 131:7-13.
19. Lehto S., Niskanen L., Ronnemaa T., Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998, 29:635-639.
20. Quiniones Galvan A., Natali A., Baldi S., et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995, 268:E1-E5.
21. Muscelli E., Natali A., Bianchi S., et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996, 9:746-752.
22. Cook D.G., Shaper A.G., Thelle D.S., Whitehead T.P. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986, 62:1001-1006.
23. Strasak A.M., Lang S., Kneib T., et al. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men. Ann Epidemiol 2009, 19:15-24.
24. Strasak A.M., Rapp K., Hilbe W., et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 2007, 18:1021-1029.
25. Strasak A.M., Rapp K., Hilbe W., et al. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol 2007, 18:1893-1897.
26. Levine W., Dyer A.R., Shekelle R.B., Schoenberger J.A., Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection project in Industry. J Clin Epidemiol 1989, 42:257-267.
27. Loh W.J., North B.V., Johnston D.G., Godsland I.F. Insulin resistance-related biomarker clustering and subclinical inflammation as predictors of cancer mortality during 21.5 years of follow-up. Cancer Causes Control 2010, 21:709-718.
28. Boffetta P., Nordenvall C., Nyrén O., Ye W. A prospective study of gout and cancer. Eur J Cancer Prev 2009, 18:127-132.